Global Biopharmaceutical Market 2022 Industry Overview, Share, Trend, Segmentation and Forecast to 2031


Posted May 24, 2022 by BhushanMRFR

Biopharmaceutical Market 2022 Development Trend, Chain Suppliers, Key Players Analysis and Forecast to 2031

 
Biopharmaceutical Market 2022

The Biopharmaceutical Market is expected to grow on a decent note, at a CAGR of 9.4% between 2022-2027. VR-based healthcare solution providers are creating ripples and are expected to continue with the same even in the forecast period. The services include critical procedure simulations, medical training, stroke rehabilitation, non-motor and motor rehabilitation, pain relief, autism care, anxiety reduction, and even battling depression. This would be the case with the healthcare vertical shortly.

According to a new market report published by Persistence Market Research “Global Market Study on Biopharmaceuticals: Asia to Witness Highest Growth by 2020”, the global biopharmaceuticals market was valued at US$ 162 Bn in 2014 and is expected to grow at a CAGR of 9.4% from 2014 to 2020, to reach an estimated value of US$ 278 Bn by 2020.

Biopharmaceuticals are medicinal drugs, produced by isolation of the medicinal products from biological sources such as animals, plants, humans, and microorganisms, using biotechnological techniques such as recombinant DNA technology.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/2827

They can also be produced using transgenic organisms, particularly animals and plants that have been genetically engineered to produce drugs. These drugs help in the prevention and treatment of various diseases such as rheumatoid arthritis, psoriatic arthritis, psoriasis, cardiovascular disease, anemia arising from chemotherapy, chronic renal failure, cancer, and diabetes.

Some of the major players in the Biopharmaceuticals market:

Pfizer, Inc.
F. Hoffmann-La Roche AG.
Johnson & Johnson Services, Inc.
Sanofi, Amgen Inc.
AbbVie Inc.
Merck & Co., Inc.
Biogen Idec.
Bayer AG.
Eli Lilly and Company.
Novartis AG GlaxoSmithKline Plc.
Bristol-Myers Squibb Company.
AstraZeneca PLC.
Abbott Laboratories.
Other

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/2827

Globally, the biopharmaceuticals market is witnessing significant growth due to increasing prevalence of chronic diseases, rising aging population, technological advancements in biopharmaceuticals, and increasing R&D investments. In addition, the capability of biopharmaceuticals to approach a particular target with high efficacy helps in the treatment of various chronic diseases and disorders.

Biopharmaceuticals, such as monoclonal antibodies, hormones, cytokines, clotting factors, cell therapies, antisense drugs, recombinant insulin, and vaccines, have the potential to prevent, treat, and completely heal the diseases which are otherwise difficult to cure or have no available treatment. This, in turn, fuels growth of the biopharmaceuticals market. However, factors such as high costs of biopharmaceuticals, the risk of side–effects, and availability of low-cost biosimilars are restraining the growth of the global market for biopharmaceuticals.

North America is the largest market for biopharmaceuticals. This is due to technological advancements in the region. The North America market for biopharmaceuticals was valued at US$ 64.7 Bn in 2014 and is expected to reach US$ 111.5 Bn by 2020 at a CAGR of 9.5% over the forecast period. In terms of type, monoclonal antibodies are the fastest growing segment. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market. Biopharmaceuticals have wide applications in the pharmaceutical industry.

One of the latest trends in the global biopharmaceuticals market is that of outsourcing, where biopharmaceutical companies are dependent on contract manufacturing organizations to produce a biopharmaceutical drug substance, which helps reducing investments for a new product launch.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/2827

The biopharmaceuticals market is segmented as follows:

By Type

Monoclonal antibodies
Erythropoietin
Granulocyte-colony stimulating factor (G-CSF)
Purified proteins
Recombinant proteins
Recombinant human insulin
Growth hormones
Interferon
Vaccines
Others

By Therapeutic applications

Metabolic disorders
Oncology
Neurological disorders
Cardiovascular diseases
Inflammatory and infectious diseases

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Persistence Market Research
Phone 6465687751
Business Address 305 Broadway,7th Floor New York City, NY 10007 United States
Persistence Market Research
Country United States
Categories Health
Tags biopharmaceutical market
Last Updated May 24, 2022